Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

No comments:

Post a Comment

< + > Making AI and NLP Affordable and Trusted in Health Care

emtelligent offers a variety of AI-based services in health care. In a recent interview at the HLTH conference with Tim O’Connell, MD, Co-F...